Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy
Top Cited Papers
- 1 May 2013
- journal article
- Published by Elsevier BV in Kidney International
- Vol. 83 (5), 940-948
- https://doi.org/10.1038/ki.2012.486
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Rituximab-Induced Depletion of Anti-PLA2R Autoantibodies Predicts Response in Membranous NephropathyJournal of the American Society of Nephrology, 2011
- Anti-Phospholipase A2 Receptor Antibodies Correlate with Clinical Status in Idiopathic Membranous NephropathyClinical Journal of the American Society of Nephrology, 2011
- Anti-Phospholipase A2 Receptor Antibody in Membranous NephropathyJournal of the American Society of Nephrology, 2011
- An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritisNephrology Dialysis Transplantation, 2011
- Divergent Motifs but Overlapping Binding Repertoires of Six HLA-DQ Molecules Frequently Expressed in the Worldwide Human PopulationThe Journal of Immunology, 2010
- A new DQA1 allele (DQA1*0510) in a Spanish celiac disease patientTissue Antigens, 2010
- The Immune Epitope Database 2.0Nucleic Acids Research, 2009
- M-Type Phospholipase A2Receptor as Target Antigen in Idiopathic Membranous NephropathyNew England Journal of Medicine, 2009
- Idiopathic membranous nephropathy: Definition and relevance of a partial remissionKidney International, 2004
- A DQA1 allele is strongly associated with idiopathic membranous nephropathyTissue Antigens, 1989